Table 3.

Clinical and Immune Responses in Individual Patients

Patient	BATs Dose, 109	Current Disease Status	Bone Marrow CMPC Status Post-BATs	Anti-SOX2 Level Post-SCT	TTP Post- SCT, mo	Survival Post-SCT, mo
1	24	REL			6.4	26.7
2	30 *	uCR				69.30
3	20	REL			26.2	66.93
4	20	REL->SD	NC		3.3	64.90
5	20	REL-alloBMT†			15.8	63.67
6	30*	REL			42.4	63.97
7	20	uCR				62.73
8	20	uCR				62.57
9	20	uCR				62.50
10	20	REL			22.3	57.67
11	30*	REL			14.8	56.90
12	30*	uCR				56.50

NC indicates no change; alloBMT, allogeneic bone marrow transplantation.

^*Received a 10⁹ BATs booster dose.

^†Received allogeneic SCT while in partial remission.